INNOSPEC INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 121.1 USD | +0.85% |
|
-0.95% | -1.72% |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 2,534 | 2,230 | 2,227 | 2,547 | 3,064 | 3,012 | - |
| Enterprise Value (EV) 1 | 2,517 | 2,125 | 2,227 | 2,400 | 3,064 | 2,774 | 2,722 |
| P/E ratio | 22.8 x | 78.2 x | 24.1 x | 19.3 x | 22.2 x | 19.1 x | 17.5 x |
| Yield | 0.99% | 1.15% | 1.28% | - | 1.14% | 1.23% | 1.3% |
| Capitalization / Revenue | 1.67 x | 1.87 x | 1.5 x | 1.3 x | 1.57 x | 1.49 x | 1.43 x |
| EV / Revenue | 1.66 x | 1.78 x | 1.5 x | 1.22 x | 1.57 x | 1.37 x | 1.29 x |
| EV / EBITDA | 12.5 x | 19.5 x | 12.5 x | 10.6 x | 14.6 x | 11.3 x | 10.2 x |
| EV / FCF | 19.1 x | 18.3 x | 41.2 x | 57 x | 21.1 x | 23.1 x | 19.7 x |
| FCF Yield | 5.23% | 5.47% | 2.43% | 1.75% | 4.74% | 4.33% | 5.07% |
| Price to Book | 2.76 x | - | - | - | - | - | - |
| Nbr of stocks (in thousands) | 24,496 | 24,580 | 24,647 | 24,765 | 24,866 | 24,868 | - |
| Reference price 2 | 103.4 | 90.73 | 90.34 | 102.9 | 123.2 | 121.1 | 121.1 |
| Announcement Date | 2/18/20 | 2/16/21 | 2/15/22 | 2/21/23 | 2/13/24 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 1,513 | 1,193 | 1,483 | 1,964 | 1,949 | 2,024 | 2,110 |
| EBITDA 1 | 201.8 | 108.9 | 178.2 | 225.4 | 210.6 | 244.9 | 265.9 |
| EBIT 1 | 149.9 | 33.7 | 132.1 | 187.3 | 161.6 | 204.8 | 226.1 |
| Operating Margin | 9.91% | 2.82% | 8.91% | 9.54% | 8.29% | 10.12% | 10.72% |
| Earnings before Tax (EBT) 1 | 150.4 | 39.7 | 134.4 | 184.6 | 174.4 | 212.7 | 233.8 |
| Net income 1 | 112.2 | 28.7 | 93.1 | 133 | 139.1 | 159.5 | 175.4 |
| Net margin | 7.41% | 2.41% | 6.28% | 6.77% | 7.14% | 7.88% | 8.31% |
| EPS 2 | 4.540 | 1.160 | 3.750 | 5.320 | 5.560 | 6.335 | 6.930 |
| Free Cash Flow 1 | 131.7 | 116.2 | 54.1 | 42.1 | 145.2 | 120.1 | 137.9 |
| FCF margin | 8.7% | 9.74% | 3.65% | 2.14% | 7.45% | 5.93% | 6.54% |
| FCF Conversion (EBITDA) | 65.26% | 106.7% | 30.36% | 18.68% | 68.95% | 49.04% | 51.86% |
| FCF Conversion (Net income) | 117.38% | 404.88% | 58.11% | 31.65% | 104.39% | 75.28% | 78.64% |
| Dividend per Share 2 | 1.020 | 1.040 | 1.160 | - | 1.410 | 1.495 | 1.575 |
| Announcement Date | 2/18/20 | 2/16/21 | 2/15/22 | 2/21/23 | 2/13/24 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 376.1 | 413.2 | 472.4 | 467.6 | 513 | 510.7 | 509.6 | 480.4 | 464.1 | 494.7 | 504 | 499.3 | 509.1 | 511.8 | 515.8 |
| EBITDA 1 | 41.4 | 44.8 | 59 | 52.9 | 59.2 | 54.3 | 53.9 | 46.2 | 56.5 | 54 | 59.57 | 58.9 | 61.97 | 65.9 | 67.5 |
| EBIT 1 | 31.4 | 35.5 | 44.3 | 46.3 | 50.1 | 46.6 | 41 | 34.2 | 41.9 | 44.5 | 49.93 | 49.4 | 51.93 | 53.57 | 56.5 |
| Operating Margin | 8.35% | 8.59% | 9.38% | 9.9% | 9.77% | 9.12% | 8.05% | 7.12% | 9.03% | 9% | 9.91% | 9.89% | 10.2% | 10.47% | 10.95% |
| Earnings before Tax (EBT) 1 | 30.8 | 32.7 | 48.2 | 42.3 | 48.9 | 45.2 | 45 | 36.6 | 47.5 | 45.3 | 51.53 | 51.1 | 53.8 | 56.3 | 59.6 |
| Net income 1 | 23.4 | 23.9 | 36.5 | 32.3 | 38.7 | 25.5 | 33.2 | 28.9 | 39.2 | 37.8 | 38.67 | 38.33 | 40.37 | 42.23 | 44.7 |
| Net margin | 6.22% | 5.78% | 7.73% | 6.91% | 7.54% | 4.99% | 6.51% | 6.02% | 8.45% | 7.64% | 7.67% | 7.68% | 7.93% | 8.25% | 8.67% |
| EPS 2 | 0.9400 | 0.9600 | 1.460 | 1.290 | 1.550 | 1.020 | 1.330 | 1.160 | 1.570 | 1.510 | 1.515 | 1.550 | 1.605 | 1.660 | 1.790 |
| Dividend per Share 2 | - | 0.5900 | - | 0.6300 | - | - | - | 0.6900 | - | 0.7200 | - | 0.7400 | - | 0.7550 | - |
| Announcement Date | 11/2/21 | 2/15/22 | 5/3/22 | 8/2/22 | 11/8/22 | 2/21/23 | 5/3/23 | 8/8/23 | 11/7/23 | 2/13/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - |
| Net Cash position 1 | 17.1 | 105 | - | 147 | - | 238 | 290 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow 1 | 132 | 116 | 54.1 | 42.1 | 145 | 120 | 138 |
| ROE (net income / shareholders' equity) | - | - | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - |
| Book Value Per Share | 37.50 | - | - | - | - | - | - |
| Cash Flow per Share | 6.540 | - | - | - | - | - | - |
| Capex 1 | 29.9 | 29.7 | 39.1 | 39.6 | 62.1 | 60 | 60 |
| Capex / Sales | 1.98% | 2.49% | 2.64% | 2.02% | 3.19% | 2.96% | 2.84% |
| Announcement Date | 2/18/20 | 2/16/21 | 2/15/22 | 2/21/23 | 2/13/24 | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
121.1
USD
Average target price
132.5
USD
Spread / Average Target
+9.40%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -1.72% | 3.01B | |
| +11.47% | 63.22B | |
| -3.47% | 46.34B | |
| +13.72% | 39.97B | |
| +17.83% | 25.46B | |
| +7.27% | 18.68B | |
| -0.57% | 17.24B | |
| -21.73% | 15.81B | |
| +0.22% | 14.9B | |
| -19.10% | 13.74B |
- Stock Market
- Equities
- IOSP Stock
- Financials Innospec Inc.
